Google+ Badge

Sunday, April 13, 2014

4/13/14 Health News: HEPATITIS A VACCINES URGED FOR NYACK LA FONTANA PATRONS ♦ Muscle Paralysis Eased by Light-sensitive Stem Cells ♦ Tamiflu-resistant Flu ♦ New Anti-MRSA Agents

HEPATITIS A VACCINES URGED FOR NYACK LA FONTANA PATRONS
The Rockland County Department of Health has confirmed a case of acute Hepatitis A in a food handler at the La Fontana restaurant in Nyack, NY. Patrons and other employees may have been exposed to the Hepatitis A virus between March 19 and April 1, 2014. The health department will offer free Hepatitis A vaccine... Continue Reading

Muscle Paralysis Eased by Light-sensitive Stem Cells
A genetic tweak can make light work of some nervous disorders. Using flashes of light to stimulate modified neurons can restore movement to paralysed muscles. A study demonstrating this, carried out in mice, lays the path for using these approaches to treat nerve disorders ranging from spinal cord injury to epilepsy and motor neuron disease. Continue Reading

Scientists Study Genome of Tamiflu-resistant Flu
Tamiflu is one of the few available treatments for those who come down with the flu. But the virus quickly develops resistance; multiplying at a rate of several generations a day, these tiny pathogens rapidly accumulate genetic mutations. Because of this, they have a good chance of developing counterattacks to the antiviral. How can these infinitesimal variations be identified within the immensity of the virus’ genetic code? EPFL researchers have created a computer tool that can shed light on the flu virus’ formidable adaptability.Continue reading

FDA Panel Recommends 2 New Anti-MRSA Agents

The Anti-Infective Drugs Advisory Committee of the US Food and Drug Administration (FDA) has voted unanimously to recommend approval of 2 new antibacterial agents for the treatment of skin and skin structure infections caused by gram-positive pathogens, including methicillin-resistantStaphylococcus aureus (MRSA). The 2 drugs are tedizolid phosphate (Sivextro,Continue Reading

No comments:

Post a Comment